Emel Başak Gencer Akçok

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Histone Deacetylase

Acute Myeloid Leukemia

St Segment Elevation Myocardial Infarction

Top Venues

Medical oncology (Northwood, London, England)

Molecular diversity

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Emel Başak Gencer Akçok, Hüseyin Güner, Huseyin Guner
Determination of promising inhibitors for N-SH2 domain of SHP2 tyrosine phosphatase: an in silico study. Molecular diversity (2024)
Havva Berre Ayvaz, Münevver Yenigül, Emel Başak Gencer Akçok
Tomatidine, a Steroidal Alkaloid, Synergizes with Cisplatin to Inhibit Cell Viability and Induce Cell Death Selectively on FLT3-ITD+ Acute Myeloid Leukemia Cells. Cell biochemistry and biophysics (2024)
Merve Şansaçar, Emel Başak Gencer Akçok
Measurement of Autophagic Activity in Cancer Cells with Flow Cytometric Analysis Using Cyto-ID Staining. Methods in molecular biology (Clifton, N.J.) (2024)
Münevver Yenigül, Emel Başak Gencer Akçok
Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells. ACS omega 8 (24) (2023)
Münevver Yenigül, Emel Başak Gencer Akçok
Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells. ACS omega 8 (24) (2023)
Merve Şansaçar, Helin Sağır, Emel Başak Gencer Akçok
Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells. Medical oncology (Northwood, London, England) 41 (1) (2023)
Merve Şansaçar, Helin Sağır, Emel Başak Gencer Akçok
Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells. Medical oncology (Northwood, London, England) 41 (1) (2023)
Merve Şansaçar, Helin Sağır, Emel Başak Gencer Akçok
Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells. Medical oncology (Northwood, London, England) 41 (1) (2023)
Münevver Yenigül, İsmail Akçok, Emel Başak Gencer Akçok
Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells. Molecular biology reports 49 (8) (2022)